ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 131 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $217,000 | -60.5% | 2,573 | -55.3% | 0.02% | -59.1% |
| Q1 2019 | $550,000 | +70.3% | 5,759 | +26.2% | 0.04% | +76.0% |
| Q4 2018 | $323,000 | -11.7% | 4,562 | +13.2% | 0.02% | +8.7% |
| Q3 2018 | $366,000 | -29.3% | 4,029 | -9.9% | 0.02% | -25.8% |
| Q2 2018 | $518,000 | -79.8% | 4,470 | -85.9% | 0.03% | -76.3% |
| Q1 2018 | $2,559,000 | +40.2% | 31,627 | +1.7% | 0.13% | +40.9% |
| Q4 2017 | $1,825,000 | +29.5% | 31,099 | +3.3% | 0.09% | +20.8% |
| Q3 2017 | $1,409,000 | +24.0% | 30,102 | -4.6% | 0.08% | +18.5% |
| Q2 2017 | $1,136,000 | +17.5% | 31,565 | +0.6% | 0.06% | +16.1% |
| Q1 2017 | $967,000 | -18.3% | 31,392 | -11.1% | 0.06% | -24.3% |
| Q4 2016 | $1,183,000 | -0.9% | 35,326 | -21.3% | 0.07% | -2.6% |
| Q3 2016 | $1,194,000 | +17.6% | 44,871 | -2.5% | 0.08% | +10.1% |
| Q2 2016 | $1,015,000 | -32.9% | 46,015 | -10.7% | 0.07% | -37.3% |
| Q1 2016 | $1,513,000 | +2.2% | 51,525 | +14.9% | 0.11% | -1.8% |
| Q4 2015 | $1,480,000 | +85.2% | 44,836 | +382.0% | 0.11% | +38.3% |
| Q3 2015 | $799,000 | -15.1% | 9,302 | -55.5% | 0.08% | -16.5% |
| Q2 2015 | $941,000 | – | 20,914 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |